NeoGenomics Inc (NEO) — Capital Reinvestment Ratio
NeoGenomics Inc (NEO) has a Capital Reinvestment Ratio of 5.86x as of December 2025, meaning it reinvests 6% of its operating cash flow ($1.34 Million) in capital expenditures ($7.87 Million). See NeoGenomics Inc balance sheet quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
NeoGenomics Inc Capital Reinvestment Ratio (2011–2025)
This chart tracks NeoGenomics Inc's Capital Reinvestment Ratio across 11 annual periods. Check NeoGenomics Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for NeoGenomics Inc (2011–2025)
Year-by-year Capital Reinvestment Ratio for NeoGenomics Inc from 2011 to 2025. For live market cap and broader valuation context, see NEO stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 5.16x | $5.23 Million | $27.01 Million | ▼ -11.7% |
| 2024 | 5.85x | $7.02 Million | $41.06 Million | ▼ -70.7% |
| 2020 | 19.93x | $1.46 Million | $29.10 Million | ▲ +2225.2% |
| 2019 | 0.86x | $23.37 Million | $20.03 Million | ▲ +168.2% |
| 2018 | 0.32x | $44.79 Million | $14.31 Million | ▼ -57.9% |
| 2017 | 0.76x | $18.04 Million | $13.69 Million | ▲ +116.3% |
| 2016 | 0.35x | $21.48 Million | $7.54 Million | ▲ +1.3% |
| 2015 | 0.35x | $6.39 Million | $2.21 Million | ▼ -13.2% |
| 2014 | 0.40x | $9.45 Million | $3.77 Million | ▼ -55.8% |
| 2013 | 0.90x | $2.23 Million | $2.01 Million | ▼ -93.1% |
| 2011 | 13.00x | $69.00K | $897.00K | — |